A reference work, not a recommendation to use: this profile describes mechanism and evidence and does not replace medical advice. The claims come from marketing and forums and are tested here, not endorsed.

Claims checked

  • More performance in intense efforts of 1 to 4 minutes

    Small benefit

    Muscle & performance · healthy · Human, randomised

    Meta-analyses: median improvement 2.85% with benefit at 60–240 s [4], overall effect 0.18, clear in capacity tests, not significant in performance tests [5]; effect size 0.39 in trained people [6].

  • Faster sprints under one minute

    No benefit

    Muscle & performance · healthy · Human, randomised

    No benefit in efforts under 60 seconds in the meta-analysis [4]; exercise duration moderates the effect [5].

  • More muscle mass, less fat

    No benefit

    Muscle & performance · healthy · Human, randomised

    Meta-analysis of 20 RCTs: no effect on body weight, fat mass, body fat percentage or fat-free mass, not even in combination with training [9].

Mechanism of action

Evidence map: Beta-alanine

Each line stands for a published finding; line style and color show where it comes from. The filter hides weaker evidence levels. Sources: see references.

In muscle, beta-alanine combines with histidine to form carnosine. After oral intake, beta-alanine rose rapidly in plasma and was back to baseline after 2 hours, with less than 5% lost in urine; supplemented over four weeks, it raised the carnosine content of thigh muscle by 42 to 64% [1]. In a placebo-controlled study with muscle biopsies, carnosine rose by 58.8% after four and by 80.1% after ten weeks, equally in type I and type IIa fibers; taurine remained unchanged, and the work done in a cycling test at 110% of maximal power increased by 13% [2]. Both studies used the same branded product. The typical tingling goes back to a different pathway: in mice, beta-alanine triggered itch behavior via the G protein-coupled receptor MrgprD on sensory neurons supplying the skin, and in humans, beta-alanine injected into the skin caused itch without wheal or redness, i.e., independent of histamine [3].

An early meta-analysis of 15 studies with 360 participants found a median improvement of 2.85%, driven by efforts between 60 and 240 seconds and longer, but not under 60 seconds; mainly exercise capacity was improved, not time-trial performance [4]. A larger meta-analysis of 40 double-blind, placebo-controlled studies with 1461 participants yielded a small overall effect size of 0.18; exercise duration moderated the effect, and in the range of 0.5 to 10 minutes, capacity tests clearly benefited, performance tests not significantly [5]. In trained young men, a meta-analysis of 18 studies found an effect size of 0.39 for maximal efforts of 0.5 to 10 minutes [6]. A position statement by a sports nutrition society, in which people with company affiliations also took part, describes carnosine as an intracellular pH buffer and sees the clearest benefit in efforts of 1 to 4 minutes [7].

A systematic risk assessment of 101 human and 50 animal studies found paresthesia as the only reported side effect (odds ratio 8.9), a similar number of study dropouts as with placebo, a small rise in the liver aminotransferase ALT within the reference range and, in humans, no effect on taurine or histidine in muscle [8]. On body composition, beta-alanine had no effect in a meta-analysis of 20 RCTs with 492 participants, neither on fat mass nor on fat-free mass [9].

Synaptik serves solely to explain biochemistry and pharmacology and is not medical advice or a recommendation to take anything.

Mechanism of action only. Schematic longitudinal section through the edge of a skeletal muscle fibre with a capillary, not to scale. The figure alternates between rest with insulin and a short bout of exercise. Particles, speeds and the bars of the live readout are model outputs (illustrative) and only show the direction reported by the studies; the numbers in the readout and the text come from the studies cited.
Compound
View

insulin  glucose  H⁺  phosphocreatine  bicarbonate  compound  glow = active signalling node

Beta-alanine is the precursor of carnosine (β-alanyl-L-histidine), which carnosine synthase forms from beta-alanine and histidine [13]. In a placebo-controlled study of 25 men, 12 of whom were biopsied (6 each on beta-alanine and placebo), carnosine rose by 58.8% after four and by 80.1% after ten weeks, equally in type I and type IIa fibres [15]. Carnosine is regarded as an intracellular pH buffer; the clearest performance benefit is seen in exercise lasting about one to four minutes [16]. In the model, more carnosine molecules capture H⁺.

Tap or focus a labelled part for a short explanation.

Also acting here, not drawn

Targets

TargetTypeActionKey dataEvidence
Carnosine synthesis in muscle (beta-alanine as the limiting substrate)EnzymeBindingMuscle carnosine +58.8% after 4 and +80.1% after 10 weeks (biopsy, vs. placebo) Human, randomised[1][2]
MrgprD (Mas-related G-protein coupled receptor D) on skin nervesReceptorAgonistItch behavior in mice MrgprD-dependent; in humans histamine-independent itch after injection into the skin Animal study[3]

Effect profile

Which signaling systems the compound affects according to current data. ↑ enhanced, ↓ dampened, ≈ modulated, ○ no effect; dots = evidence level.

  • Dopamineno data
  • Noradrenalineno data
  • Serotoninno data
  • Acetylcholineno data
  • Glutamate · AMPAno data
  • Glutamate · NMDAno data
  • GABAno data
  • Histamineno data
  • Orexinno data
  • Adenosineno data
  • Opioidsno data
  • Melatoninno data
  • Neurotrophinsno data
  • Blood flowno data
  • Nitric oxideno data
  • Energy metabolism↑ · more muscle carnosine, which buffers hydrogen ions during intense exertion; small performance benefit in efforts of about 1 to 4 minutes[1][2][5][7]
  • Insulin · glucoseno data
  • Inflammation · oxidativeno data
  • Stress axisno data
  • Testosterone axisno data
  • Endocannabinoidsno data
  • Autophagy · senescenceno data
  • Immune systemno data
  • Lipid metabolismno data
  • Coagulation · fibrinolysisno data
  • Methylationno data

Routes of administration and bioavailability

How much of a compound reaches the blood or target tissue depends on the route into the body and on the dosage form. All routes of administration explained

  • Oral (swallowed) · Powder or capsule

    < 5% loss via urine (human)

    Rapid rise in plasma, back to baseline after 2 hours [1]. The effect does not depend on acute absorption but on the muscle carnosine built up over weeks [1][2].[2]

    Human, non-randomised

Human studies

  • Meta-analysis 40 studies performance

    systematic review and three-level meta-analysis of double-blind, placebo-controlled studies · healthy · n = 1461 · chronic intake

    Measured: Exercise capacity and performance

    Result: Effect size 0.18 (95% CI 0.08–0.28); 0.5–10 min: capacity 0.50, performance 0.11 (not significant); training status without influence.[5]

    Human, randomised

  • Early meta-analysis by exercise duration

    meta-analysis of placebo-controlled studies · healthy · n = 360 · chronic intake

    Measured: Exercise measures

    Result: Median +2.85%; benefit at 60–240 s (p = 0.001) and > 240 s (p = 0.046), not < 60 s (p = 0.312).[4]

    Human, randomised

  • Meta-analysis trained young men

    systematic review and meta-analysis of randomized, double-blind studies · healthy (trained, men 18–40 years) · n = 331 · chronic intake

    Measured: maximal efforts of 0.5–10 min

    Result: Effect size 0.39 (95% CI 0.09–0.69); 4–10 min 0.55.[6]

    Human, randomised

  • Muscle carnosine and cycling performance

    placebo-controlled, muscle biopsies in 12 of the 25 (6 each on active treatment and placebo) · healthy (men) · n = 25 · 4 and 10 weeks

    Measured: Muscle carnosine, taurine, work done at 110% of maximal power

    Result: Carnosine +58.8% and +80.1%, taurine unchanged, work +13.0% after 4 weeks.[2]

    Human, randomised

  • Meta-analysis body composition

    systematic review and meta-analysis of RCTs, GRADE · healthy · n = 492 · varied

    Measured: Body mass, fat mass, fat-free mass

    Result: No significant effects (fat-free mass +0.05 kg; 95% CI −0.71 to 0.82).[9]

    Human, randomised

Risks and warnings

  • Paresthesia (tingling, itch)

    The only side effect reported in studies, odds ratio 8.9 vs. placebo; dropouts not more frequent [8]. Mediated via MrgprD on sensory nerves of the skin, independent of histamine [3].

    Human, randomised

  • Liver value ALT

    Small rise in alanine aminotransferase, on average within the reference range [8].

    Human, randomised

  • Conflicts of interest

    The early carnosine studies used a branded product [1][2]; people with company affiliations contributed to the position statement [7]; a co-author of the meta-analysis on body composition reports industry-funded research [9].

    No data

Fact check: common claims

  • partly supported

    “Beta-alanine increases performance in intense efforts of 1 to 4 minutes”

    Several meta-analyses show small effects in this time range [4][5][6], clear in capacity tests to exhaustion, not significant in performance tests such as time trials [5].

  • not supported

    “The tingling shows that it works”

    The tingling arises via MrgprD on skin nerves [3], the performance effect via muscle carnosine [1][2]; a connection between the two has not been shown.

  • refuted

    “Beta-alanine builds muscle”

    Meta-analysis of 20 RCTs without effect on fat-free mass or fat mass, not even with training [9].

  • not supported

    “Beta-alanine depletes the taurine stores in muscle”

    In humans, no effect on muscle taurine [2][8]; a decrease appeared only in mice with very high intake [8].

  • not supported

    “Beta-alanine makes you faster in the sprint”

    No benefit in efforts under 60 seconds [4].

Pharmacokinetics

Absorption
Oral, rapid; plasma peak and return to baseline within 2 hours [1].
Half-life
Not verified.
Metabolism
Incorporation into muscle carnosine; less than 5% is excreted unchanged in urine [1].
Entry into the brain
Not verified.

Legal status

Germany
Not verified.
EU
Not verified.
USA
Not verified.
Other countries
One of the most widely used sports nutrition products worldwide [8]; legal status not checked.

Open questions

  • Why do capacity tests clearly benefit, but competition simulations hardly?
  • Does the higher carnosine content have effects outside muscle, for example in the brain?
  • How relevant is the small ALT rise with long-term intake?

References

  1. Harris RC, Tallon MJ, Dunnett M, Boobis L, Coakley J, Kim HJ, et al. The absorption of orally supplied beta-alanine and its effect on muscle carnosine synthesis in human vastus lateralis. Amino Acids. 2006;30(3):279–89. doi:10.1007/s00726-006-0299-9 · PubMed
  2. Hill CA, Harris RC, Kim HJ, Harris BD, Sale C, Boobis LH, et al. Influence of beta-alanine supplementation on skeletal muscle carnosine concentrations and high intensity cycling capacity. Amino Acids. 2007;32(2):225–33. doi:10.1007/s00726-006-0364-4 · PubMed
  3. Liu Q, Sikand P, Ma C, Tang Z, Han L, Li Z, et al. Mechanisms of itch evoked by β-alanine. J Neurosci. 2012;32(42):14532–7. doi:10.1523/JNEUROSCI.3509-12.2012 · PubMed
  4. Hobson RM, Saunders B, Ball G, Harris RC, Sale C. Effects of β-alanine supplementation on exercise performance: a meta-analysis. Amino Acids. 2012;43(1):25–37. doi:10.1007/s00726-011-1200-z · PubMed
  5. Saunders B, Elliott-Sale K, Artioli GG, Swinton PA, Dolan E, Roschel H, et al. β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis. Br J Sports Med. 2017;51(8):658–69. doi:10.1136/bjsports-2016-096396 · PubMed
  6. Georgiou GD, Antoniou K, Antoniou S, Michelekaki EA, Zare R, Ali Redha A, et al. Effect of beta-alanine supplementation on maximal intensity exercise in trained young male individuals: a systematic review and meta-analysis. Int J Sport Nutr Exerc Metab. 2024;34(6):397–412. doi:10.1123/ijsnem.2024-0027 · PubMed
  7. Trexler ET, Smith-Ryan AE, Stout JR, Hoffman JR, Wilborn CD, Sale C, et al. International society of sports nutrition position stand: beta-alanine. J Int Soc Sports Nutr. 2015;12:30. doi:10.1186/s12970-015-0090-y · PubMed
  8. Dolan E, Swinton PA, Painelli VS, Stephens Hemingway B, Mazzolani B, Infante Smaira F, et al. A systematic risk assessment and meta-analysis on the use of oral β-alanine supplementation. Adv Nutr. 2019;10(3):452–63. doi:10.1093/advances/nmy115 · PubMed
  9. Ashtary-Larky D, Bagheri R, Ghanavati M, Asbaghi O, Wong A, Stout JR, et al. Effects of beta-alanine supplementation on body composition: a GRADE-assessed systematic review and meta-analysis. J Int Soc Sports Nutr. 2022;19(1):196–218. doi:10.1080/15502783.2022.2079384 · PubMed
How this profile was checked

Last reviewed: 2026-10-25. All sources with a DOI or PMID were resolved automatically via Crossref or doi.org and PubMed.

Translated from the German profile (version of 2026-10-25); translation checked on 2026-10-26.

Checked

  • October 25, 2026: [2] checked again against the abstract: biopsies in 6 of the 8 participants on active treatment (10 weeks) and in 5 of the 8 participants on placebo plus one further person; n = 25 is the total number of participants.
  • Checked against the abstract: plasma peak, return after 2 h, urinary loss < 5%, muscle carnosine +42.1% and +64.2% after 4 weeks, branded product [1]; carnosine +58.8% and +80.1%, type I and IIa, taurine unchanged, TWD +13.0%, 13 participants on active treatment and 12 on placebo [2]; MrgprD in mice, histamine-independent itch in humans [3]; 15 studies, 360 participants, median 2.85%, p values by duration [4]; 40 studies, 1461 participants, ES 0.18, capacity 0.50 vs. performance 0.11 [5]; 18 studies, 331 participants, ES 0.39, 4–10 min 0.55 [6]; pH buffer, 1–4 min, company affiliations of authors according to the affiliations [7]; 101 human and 50 animal studies, OR 8.9, ALT ES 0.274, taurine and histidine unchanged [8]; 20 RCTs, 492 participants, no effects, conflict of interest of one co-author [9].
  • All DOIs checked via Crossref and all PMIDs via PubMed (checking script).

Not verified

  • Legal status of beta-alanine in Germany, the EU and the USA.
  • Whether the authors of [1] and [2] were employed by the manufacturer of the branded product used or held patents (only the product mention in the abstract checked).
  • Randomization in [2] not described in the abstract (only “matched subjects received a placebo”).

No dosages, no sources of supply. This information does not replace medical advice.

Spotted an error or missing something?

Request a compound, suggest an improvement or report an error. Every message is read.

Type of message

The website stores nothing. The button opens your email app with a pre-filled message.